SUBSTITUTED TETRACYCLINE COMPOUNDS

The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compound...

Full description

Saved in:
Bibliographic Details
Main Authors BHATIA BEENA, GRIER MARK, OHEMENG KWASI, ASSEFA HAREGEWEIN, NELSON MARK L, BOWSER TODD, ABATO PAUL, HONEYMAN LAURA, BERNIAC JOEL, KIM OAK K, ISMAIL MOHAMED Y, MECHICHE RACHID, AMOO VICTOR, MATHEWS JUDE, CHEN JACKSON
Format Patent
LanguageEnglish
Published 12.02.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
Bibliography:Application Number: US201414281357